Literature DB >> 22984022

Epigenomics of idiopathic pulmonary fibrosis: evaluating the first steps.

Einat I Rabinovich, Moisés Selman, Naftali Kaminski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22984022      PMCID： PMC3480530          DOI： 10.1164/rccm.201208-1350ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  13 in total

1.  Altered DNA methylation profile in idiopathic pulmonary fibrosis.

Authors:  Yan Y Sanders; Namasivayam Ambalavanan; Brian Halloran; Xiangyu Zhang; Hui Liu; David K Crossman; Molly Bray; Kui Zhang; Victor J Thannickal; James S Hagood
Journal:  Am J Respir Crit Care Med       Date:  2012-06-14       Impact factor: 21.405

2.  Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis.

Authors:  Yan Y Sanders; Annie Pardo; Moisés Selman; Gerard J Nuovo; Trygve O Tollefsbol; Gene P Siegal; James S Hagood
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-12       Impact factor: 6.914

3.  Inhibition and role of let-7d in idiopathic pulmonary fibrosis.

Authors:  Kusum V Pandit; David Corcoran; Hanadie Yousef; Manohar Yarlagadda; Argyris Tzouvelekis; Kevin F Gibson; Kazuhisa Konishi; Samuel A Yousem; Mandal Singh; Daniel Handley; Thomas Richards; Moises Selman; Simon C Watkins; Annie Pardo; Ahmi Ben-Yehudah; Demosthenes Bouros; Oliver Eickelberg; Prabir Ray; Panayiotis V Benos; Naftali Kaminski
Journal:  Am J Respir Crit Care Med       Date:  2010-04-15       Impact factor: 21.405

4.  Hypermethylation-mediated silencing of p14(ARF) in fibroblasts from idiopathic pulmonary fibrosis.

Authors:  José Cisneros; James Hagood; Marco Checa; Blanca Ortiz-Quintero; Miguel Negreros; Iliana Herrera; Carlos Ramos; Annie Pardo; Moisés Selman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-06-15       Impact factor: 5.464

Review 5.  Idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Annie Pardo; Moisés Selman
Journal:  Lancet       Date:  2011-06-28       Impact factor: 79.321

Review 6.  Epigenetic control of gene expression in the lung.

Authors:  Ivana V Yang; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2011-05-15       Impact factor: 21.405

7.  miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis.

Authors:  Gang Liu; Arnaud Friggeri; Yanping Yang; Jadranka Milosevic; Qiang Ding; Victor J Thannickal; Naftali Kaminski; Edward Abraham
Journal:  J Exp Med       Date:  2010-07-19       Impact factor: 14.307

Review 8.  Epigenetic modifications as therapeutic targets.

Authors:  Theresa K Kelly; Daniel D De Carvalho; Peter A Jones
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

9.  Increased methylation variation in epigenetic domains across cancer types.

Authors:  Kasper Daniel Hansen; Winston Timp; Héctor Corrada Bravo; Sarven Sabunciyan; Benjamin Langmead; Oliver G McDonald; Bo Wen; Hao Wu; Yun Liu; Dinh Diep; Eirikur Briem; Kun Zhang; Rafael A Irizarry; Andrew P Feinberg
Journal:  Nat Genet       Date:  2011-06-26       Impact factor: 38.330

10.  Global methylation patterns in idiopathic pulmonary fibrosis.

Authors:  Einat I Rabinovich; Maria G Kapetanaki; Israel Steinfeld; Kevin F Gibson; Kusum V Pandit; Guoying Yu; Zohar Yakhini; Naftali Kaminski
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240
View more
  9 in total

1.  Erratum: epigenomics of idiopathic pulmonary fibrosis: evaluating the first steps.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2015-06-01       Impact factor: 21.405

Review 2.  Pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Paul J Wolters; Harold R Collard; Kirk D Jones
Journal:  Annu Rev Pathol       Date:  2013-09-13       Impact factor: 23.472

Review 3.  Fibrosis: Lessons from OMICS analyses of the human lung.

Authors:  Guoying Yu; Gabriel H Ibarra; Naftali Kaminski
Journal:  Matrix Biol       Date:  2018-03-19       Impact factor: 11.583

Review 4.  Blue journal conference. Aging and susceptibility to lung disease.

Authors:  Victor J Thannickal; Mahadev Murthy; William E Balch; Navdeep S Chandel; Silke Meiners; Oliver Eickelberg; Moisés Selman; Annie Pardo; Eric S White; Bruce D Levy; Paula J Busse; Rubin M Tuder; Veena B Antony; Jacob I Sznajder; G R Scott Budinger
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

5.  CBX5/G9a/H3K9me-mediated gene repression is essential to fibroblast activation during lung fibrosis.

Authors:  Giovanni Ligresti; Nunzia Caporarello; Jeffrey A Meridew; Dakota L Jones; Qi Tan; Kyoung Moo Choi; Andrew J Haak; Aja Aravamudhan; Anja C Roden; Y S Prakash; Gwen Lomberk; Raul A Urrutia; Daniel J Tschumperlin
Journal:  JCI Insight       Date:  2019-05-16

6.  Hypersensitivity Pneumonitis With and Without Autoimmune Features: A Clinical Comparative Analysis.

Authors:  Saminder Singh Kalra; Johnny F Jaber; Bashar Alzghoul; Brandon Jansen; Ayoub Innabi; Amy B Tran; Katherine Fu; Raju Reddy; Diana C Gomez Manjarres; Divya Patel
Journal:  Lung       Date:  2022-10-18       Impact factor: 3.777

7.  Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis.

Authors:  Yan Xu; Takako Mizuno; Anusha Sridharan; Yina Du; Minzhe Guo; Jie Tang; Kathryn A Wikenheiser-Brokamp; Anne-Karina T Perl; Vincent A Funari; Jason J Gokey; Barry R Stripp; Jeffrey A Whitsett
Journal:  JCI Insight       Date:  2016-12-08

Review 8.  MicroRNAs in idiopathic pulmonary fibrosis: involvement in pathogenesis and potential use in diagnosis and therapeutics.

Authors:  Huimin Li; Xiaoguang Zhao; Hongli Shan; Haihai Liang
Journal:  Acta Pharm Sin B       Date:  2016-07-27       Impact factor: 11.413

Review 9.  More than a Genetic Code: Epigenetics of Lung Fibrosis.

Authors:  Krystian Bartczak; Adam J Białas; Mateusz J Kotecki; Paweł Górski; Wojciech J Piotrowski
Journal:  Mol Diagn Ther       Date:  2020-12       Impact factor: 4.074
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.